JP2009000343A - Multi-cell container - Google Patents

Multi-cell container Download PDF

Info

Publication number
JP2009000343A
JP2009000343A JP2007164964A JP2007164964A JP2009000343A JP 2009000343 A JP2009000343 A JP 2009000343A JP 2007164964 A JP2007164964 A JP 2007164964A JP 2007164964 A JP2007164964 A JP 2007164964A JP 2009000343 A JP2009000343 A JP 2009000343A
Authority
JP
Japan
Prior art keywords
bag
drug
discharge port
sealing member
medicine bag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007164964A
Other languages
Japanese (ja)
Other versions
JP5223244B2 (en
Inventor
Yasuhiro Muramatsu
康宏 村松
Kaoru Shimizu
馨 清水
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP2007164964A priority Critical patent/JP5223244B2/en
Publication of JP2009000343A publication Critical patent/JP2009000343A/en
Application granted granted Critical
Publication of JP5223244B2 publication Critical patent/JP5223244B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To surely open an exhaust port when opening a diaphragm in a multi-cell container for opening a closing member provided in the exhaust port by an external force applied from a medical agent bag when opening the medical agent bag. <P>SOLUTION: A seal member 30 is fixed to the end of the exhaust port 12 extending to the inside of the medical agent bag 10. A medical agent bag-side end part 30-1 of the seal member 30 is closed and the exhaust port 12 is substantially closed to the inside of the medical agent bag in an ordinary state. The seal member 30 is formed of a brittle material such as a foamed plastic material and firmly welded to the opposite inner face of a plastic film constituting the medical agent bag 10. An external force is applied to the seal member 30 at a weld portion to the medical agent bag by swelling when opening the medical agent bag, the seal member 30 is formed of the brittle material to be fractured by the external force, and the inside of the medical agent bag is communicated with the exhaust port 12 to introduce the medical agent to the exhaust port 12. <P>COPYRIGHT: (C)2009,JPO&INPIT

Description

この発明は排出ポートに設けた閉鎖部材を薬剤バッグ開通時の前記押圧力による薬剤バッグの拡開により前記接合部にて惹起される外力により破壊   In this invention, the closing member provided in the discharge port is broken by an external force caused by the joint portion by the expansion of the medicine bag by the pressing force when the medicine bag is opened.

輸液用複室容器として、可撓性若しくは軟弱フィルムを素材とする薬剤バッグの対向面を相対的に低温にて溶着して成る隔壁(弱シール部)によってそれぞれ異なった薬液を収容する複数の隔室に分離したものがある。薬剤バッグの外周には、プラスチック成型品としての排出ポートが設けられ、排出ポートは筒状に形成され、その内部空洞は一端側で一方の隔室に開口しているが、他端にはゴム栓が設けられている。患者への薬液の投与に先立って薬剤バッグを外側から加圧することによって隔壁が剥離開通せしめられ、薬剤バッグの内部空洞は一室となるため2種類の薬液は混合され、輸液セットの穿刺針によりゴム栓を穿刺し、薬剤バッグよりの薬液の投与が可能となる。従って、この種の医療用混合型複室容器においては薬液の投与に先立って隔壁の開通より両液を混合せしめる作業は必須であり、他方、隔壁の開通を行わないままで排出ポートにおけるゴム栓の穿刺を行うと、排出ポート側の隔室における薬液のみが投与されてしまうという誤操作の可能性があった。この問題点に対処する従来技術として、薬剤バッグに対する排出ポートの端面を破断可能に構成し、この破壊可能部から一体に延設される応力付与部を薬液バッグの対向面に強固に溶着し、隔室開通時の薬液バッグの膨れ変形により応力付与部を拡開させることにより排出ポートの端面を破断させ、排出ポートを薬液バッグ内部に開通させるようにしたものがある(特許文献1)。
特開2006−87904号公報
As a multi-chamber container for infusion, a plurality of partitions each containing different drug solutions by a partition wall (weak seal portion) formed by welding opposed surfaces of a drug bag made of a flexible or soft film at a relatively low temperature. Some rooms are separated. A discharge port as a plastic molded product is provided on the outer periphery of the medicine bag, the discharge port is formed in a cylindrical shape, and the internal cavity opens to one compartment on one end side, but the other end has a rubber A stopper is provided. Prior to administration of the drug solution to the patient, the septum is peeled open by pressurizing the drug bag from the outside, and the inner cavity of the drug bag becomes a single chamber, so the two types of drug solution are mixed, and the puncture needle of the infusion set A rubber stopper is punctured to allow administration of a drug solution from a drug bag. Therefore, in this type of medical mixed-type multi-chamber container, it is indispensable to mix both liquids by opening the partition prior to administration of the chemical solution. On the other hand, the rubber plug at the discharge port is left without opening the partition. When the puncture is performed, there is a possibility of an erroneous operation in which only the drug solution in the compartment on the discharge port side is administered. As a conventional technique for dealing with this problem, the end face of the discharge port for the drug bag is configured to be ruptured, and a stress applying part integrally extending from the breakable part is firmly welded to the opposite surface of the drug solution bag, There is one in which the end face of the discharge port is broken by expanding the stress applying portion by the swelling deformation of the chemical solution bag when the compartment is opened, and the discharge port is opened inside the chemical solution bag (Patent Document 1).
JP 2006-87904 A

特許文献1は、排出ポートの端面から一体に延設される応力付与部を隔壁開通時の薬液バッグの膨れ変形により拡開させることにより応力付与部より排出ポート端面に応力を付与し、この応力により排出ポート端面(破断可能部)を破壊させ、排出ポートを薬液バッグに開口させている。ところが、特許文献では、排出ポート端面(破断可能部)は排出ポートとの一体成形部であり、隔壁開通時に応力付与部から加わる力による破断可能部の破断が必ずしも確実に得られない恐れがあった。この場合、隔壁は開通しているのに排出ポートが閉じたままであり、輸液作業にそのまま移行することはできなった。   Patent Document 1 applies stress to the discharge port end surface from the stress applying portion by expanding the stress applying portion that is integrally extended from the end surface of the discharge port by the swelling deformation of the chemical bag when the partition wall is opened. Thus, the discharge port end face (breakable portion) is destroyed, and the discharge port is opened to the chemical bag. However, in the patent document, the discharge port end face (breakable portion) is an integrally formed portion with the discharge port, and there is a possibility that the breakable portion may not be surely broken by the force applied from the stress applying portion when the partition wall is opened. It was. In this case, although the partition wall was opened, the discharge port remained closed, and it was not possible to proceed directly to the infusion work.

この発明は以上の問題点に鑑みなされたもので、隔壁開通時の排出ポートの開通を確実に行わしめるようにすることを目的とする。   The present invention has been made in view of the above problems, and an object of the present invention is to reliably open the discharge port when the partition wall is opened.

この発明の複室容器は、可撓性フィルムにて形成され、内部空洞をそれぞれの薬剤の収納のための複数の隔室に分離するべく薬剤バッグと、薬剤バッグの対向面を加圧剥離可能に溶着して成る隔壁と、薬剤バッグに設けられた排出ポートと、排気ポートを通常は実質的に封止する封止部材とを備える。封止部材は発泡材のような脆弱素材にて形成され、通常は排出ポートを薬剤バッグ内部に対して実質的に封止する。ここに、実質的に封止とは少量の薬剤の通過は許容する意味で、薬剤が通過しても少量であるため誤って隔壁未開通のまま輸液を開始したとしても輸液量が少ないため異常を作業者に自覚させ、隔室開通を促す程度の流量は許容する意味である。封止部材は薬剤バッグ対向面に強固に連結され、隔壁開通時の薬剤バッグの膨れにより封止部材に外向きの力が印加され、脆弱素材にて形成された封止部材は破壊せしめられ、排出ポートは薬剤バッグ内部に開口せしめられ、薬剤バッグからの薬剤を排出ポートに導くことができる。   The multi-chamber container of the present invention is formed of a flexible film, and the drug bag and the opposite surface of the drug bag can be pressure-separated to separate the internal cavity into a plurality of compartments for storing each drug. And a discharge port provided in the drug bag, and a sealing member that normally substantially seals the exhaust port. The sealing member is formed of a fragile material such as a foam material, and normally seals the discharge port substantially against the inside of the drug bag. Here, “substantial sealing” means that a small amount of drug can be allowed to pass, and even if the drug passes, even if the infusion is inadvertently started without the septum being opened, the amount of infusion is small and abnormal. This means that the flow rate to the extent that the worker is aware of and prompts the opening of the compartment is allowed. The sealing member is firmly connected to the opposite surface of the drug bag, an outward force is applied to the sealing member due to the swelling of the drug bag when the partition wall is opened, and the sealing member formed of the fragile material is destroyed, The discharge port is opened inside the drug bag, and the drug from the drug bag can be guided to the discharge port.

封止部材は発泡材のような脆弱素材にて形成されているため、薬剤バッグ開通時に加わる外力により確実に破壊開通に至らしめることができ、未開通のまま輸液が行われてしまう、という誤作業を未然防止することができる。   Since the sealing member is made of a fragile material such as a foam material, it can be reliably opened by breaking due to an external force applied when the drug bag is opened, and an infusion is performed without being opened. Work can be prevented.

図1〜図2において、この発明の複室容器は薬剤の収納のための平坦状の薬剤バッグ10と、薬剤バッグ10の外周部に固定される排出ポート12とから構成される。薬剤バッグ10は厚さ200ミクロンといったポリエチレンフィルムなどの多層構造の可撓性フィルム(本発明の可撓性素材)を素材とする。2枚の合成樹脂フィルム切片はその外周にてその軟化温度より十分高い高温(ポリエチレンの場合は約130℃)にて加圧されることにより形成された強シール部14により封止され、実質的に矩形の袋状をなしている。この薬剤バッグ10は、上記のようなフィルムからの製袋によるものの他に、チューブ状インフレーションフィルムからの製袋や、ブロー成形による容器とすることもできる。強シール部14には懸垂孔16が穿設され、この懸垂孔16によって薬剤バッグ10を点滴台などに吊り下げ保持し、点滴や透析作業を行うことになる。   1 to 2, the multi-chamber container of the present invention includes a flat drug bag 10 for storing a drug and a discharge port 12 fixed to the outer periphery of the drug bag 10. The drug bag 10 is made of a flexible film having a multilayer structure such as a polyethylene film having a thickness of 200 microns (the flexible material of the present invention). The two pieces of the synthetic resin film are sealed at the outer periphery by a strong seal portion 14 formed by being pressed at a high temperature sufficiently higher than the softening temperature (about 130 ° C. in the case of polyethylene). It has a rectangular bag shape. The drug bag 10 may be a bag made from a tubular inflation film or a container formed by blow molding, in addition to the bag made from the film as described above. A suspension hole 16 is formed in the strong seal portion 14, and the drug bag 10 is suspended and held by the suspension hole 16 on an infusion stand or the like to perform infusion or dialysis.

薬剤バッグ10の長さ方向における中間部位において全幅にわたって弱シール部18(本発明の隔壁)が延びており、弱シール部18によって薬剤バッグ10の表裏対向内面が接着され、薬剤バッグ10の内部空洞は第1隔室20と第2隔室22とに区画される。第1隔室20に第1薬液が充填され、第2隔室22に第2薬液が充填される。本発明の隔壁としての弱シール部18は薬剤バッグ10を形成する合成樹脂フィルム切片の表裏面をその軟化温度よりやや高い低温(ポリエチレンの場合は120℃)加圧することにより形成される。そのため、第1隔室20と第2隔室22にそれぞれの薬液を収容した状態で隔室20, 22の部位において薬剤バッグ10における薬液を外側より加圧することにより、強シール部14はそのままに弱シール部18を流体圧(加圧時の薬液の圧力)にて剥離・開通せしめ、隔室20, 22間で第1薬液と第2薬液との混合を行うことができる。   The weak seal portion 18 (the partition wall of the present invention) extends over the entire width at an intermediate portion in the length direction of the drug bag 10, and the inner surfaces of the drug bag 10 are bonded to each other by the weak seal portion 18. Is divided into a first compartment 20 and a second compartment 22. The first compartment 20 is filled with the first chemical solution, and the second compartment 22 is filled with the second chemical solution. The weak seal portion 18 as a partition wall of the present invention is formed by pressing the front and back surfaces of the synthetic resin film section forming the drug bag 10 at a low temperature (120 ° C. in the case of polyethylene) slightly higher than its softening temperature. Therefore, the strong seal portion 14 is left as it is by pressurizing the drug solution in the drug bag 10 from the outside in the compartments 20 and 22 with the respective drug solutions stored in the first compartment 20 and the second compartment 22. The weak seal portion 18 can be peeled and opened by fluid pressure (pressure of the chemical solution during pressurization), and the first chemical solution and the second chemical solution can be mixed between the compartments 20 and 22.

排出ポート12は、その形態を維持しうる剛性を有した肉厚を有した合成樹脂(薬剤バッグ10との密着性を得るため薬剤バッグ10と同一プラスチック素材とするのが好ましい)の成形品である。排出ポート12は両端で開口し、中間がテーパ部12-1をなし、上端にフランジ部12-2(図1)を有した筒状に形成される。フランジ部12-2にはキャップ24が突当溶着され、キャップ24の底面開口部にはゴム製内蓋(栓体)26が装着される。点滴などの輸液時には輸液セットの穿刺針により内蓋26を穿刺し、薬剤バッグ10の内部空洞を輸液チューブに連通させ、輸液を行うことになる。この実施形態においては、薬剤バッグ10の表裏面を形成する合成樹脂フィルムは排出ポート12の筒状部12-3を上下より挟みつつ強シール部14の溶着温度と同程度の高温度で加熱密着され、排出ポート12の外周でのこの密着部を14A(図4)にて表し、これにより排出ポート12に対する薬剤バッグ10の封止が行われている。   The discharge port 12 is a molded product of a synthetic resin having a rigidity and thickness capable of maintaining its form (preferably made of the same plastic material as the drug bag 10 in order to obtain adhesion to the drug bag 10). is there. The discharge port 12 has an opening at both ends, the middle forms a tapered portion 12-1, and is formed in a cylindrical shape having a flange portion 12-2 (FIG. 1) at the upper end. A cap 24 is abutted and welded to the flange portion 12-2, and a rubber inner lid (plug body) 26 is attached to the bottom opening of the cap 24. At the time of infusion such as infusion, the inner lid 26 is punctured by the puncture needle of the infusion set, and the infusion is performed by communicating the internal cavity of the drug bag 10 with the infusion tube. In this embodiment, the synthetic resin film forming the front and back surfaces of the drug bag 10 is heat-adhered at a temperature similar to the welding temperature of the strong seal portion 14 while sandwiching the cylindrical portion 12-3 of the discharge port 12 from above and below. Then, this close contact portion on the outer periphery of the discharge port 12 is represented by 14A (FIG. 4), whereby the drug bag 10 is sealed with respect to the discharge port 12.

排出ポート12の筒状部12-3は薬剤バッグ10の内部に延出し、開口端に封止部材30が設けられる。封止部材30は発泡合成樹脂のような脆弱素材にて筒状に形成され、先端部30-1において閉じた形状となっている。封止部材30は排出ポート12の筒状部12-3に開口側の一端に挿入され(図2及び図3)、溶着などにより強固に固着され、閉じた先端部30-1は薬剤バッグ10内に延出している。排出ポート12と封止部材30とは鋳込みにより成形することにより、排気ポート12と封止部材30とを一体化することも可能である。薬剤バッグ10の内部に位置する封止部材30の閉鎖端部30-1は外周に一対の平坦面30-1A(図3)を形成しており、平坦面30-1A に薬剤バッグ10を構成するプラスチックフィルム対向部がレーザ溶着等によりポイント状に溶着(ポイントシール)されている。ポイントシール部を32にて示す。このポイントシールは、封止部材30の閉鎖端部30-1の平坦面30-1Aと薬剤バッグ10を構成する合成樹脂フィルム対向内面を剥離不能に強固に接合するもので、後述の通り、弱シール部18の開通時の前記押圧力による薬剤バッグの拡開により封止部材30に引張方向の外力を加え、脆弱素材にて形成された封止部材30の確実な破壊・開通に至らしめることが可能となる。   The cylindrical portion 12-3 of the discharge port 12 extends into the drug bag 10, and a sealing member 30 is provided at the open end. The sealing member 30 is formed in a tubular shape with a fragile material such as foamed synthetic resin, and has a closed shape at the tip portion 30-1. The sealing member 30 is inserted into the cylindrical portion 12-3 of the discharge port 12 at one end on the opening side (FIGS. 2 and 3), and is firmly fixed by welding or the like. It extends in. It is also possible to integrate the exhaust port 12 and the sealing member 30 by forming the discharge port 12 and the sealing member 30 by casting. The closed end 30-1 of the sealing member 30 located inside the drug bag 10 forms a pair of flat surfaces 30-1A (FIG. 3) on the outer periphery, and the drug bag 10 is configured on the flat surface 30-1A. The plastic film facing part is welded in a point shape (point seal) by laser welding or the like. A point seal portion is indicated by 32. This point seal strongly bonds the flat surface 30-1A of the closed end 30-1 of the sealing member 30 and the inner surface facing the synthetic resin film constituting the drug bag 10 so as not to be peeled. Applying an external force in the tensile direction to the sealing member 30 by expanding the medicine bag by the pressing force when the seal portion 18 is opened, thereby leading to reliable destruction and opening of the sealing member 30 formed of a fragile material. Is possible.

排出ポート12と封止部材30との装着は必ずしも完全密封状態ではなく、少量の薬液の流通は許容するように若干の隙間は存在させることもこの発明に包含される。   The mounting of the discharge port 12 and the sealing member 30 is not necessarily in a completely sealed state, and it is also included in the present invention that a slight gap exists so as to allow a small amount of chemical liquid to flow.

薬剤バッグ10の開通時、薬剤バッグ10は机の上などに置かれ、薬剤バッグは矢印aのように隔室22又は20若しくは双方における薬液収容部位にて掌などにより加圧され、加圧により液体圧が弱シール部18の部位にかかり、弱シール部18を構成する上下の合成樹脂フィルム層を剥離・開通せしめる。弱シール部18の開封時に、薬剤バッグ10は拡開され、封止部材30は閉鎖端部30-1における外面30-1Aが薬剤バッグ10の対向内面にポイントシール部32にて強固に一体化されているため、封止部材30は閉鎖端部30-1に薬剤バッグ拡開方向の外力(図5の矢印b方向)が加わり、封止部材30は発泡合成樹脂のような脆弱素材にて形成されているため、封止部材30は閉鎖端部30-1にて図5のように破断される。即ち、封止部材30は薬剤バッグ10を構成する合成樹脂フィルムの対向面に一体化した二つの部分30A, 30Bに分割され、薬剤バッグ10の内部は排出ポート12に連通せしめられ、混合薬液を排出ポート12に流入せしめることができる。尚、外力にる封止部材30の破壊態様は必ずしも図5のように夫々の溶着部により2分割されるものに限らず、バラバラの状態に破砕されてしまうものもこの発明に含まれ、要は破壊により薬剤バッグ10内部と排出ポート12を連通するように開口部が形成されれば良い。   When the drug bag 10 is opened, the drug bag 10 is placed on a desk or the like, and the drug bag is pressurized with a palm or the like at the drug solution storage site in the compartment 22 or 20 or both as indicated by an arrow a. The liquid pressure is applied to the site of the weak seal portion 18, and the upper and lower synthetic resin film layers constituting the weak seal portion 18 are peeled and opened. When the weak seal portion 18 is opened, the drug bag 10 is expanded, and the sealing member 30 is firmly integrated with the outer surface 30-1A at the closed end 30-1 on the opposite inner surface of the drug bag 10 at the point seal portion 32. Therefore, the sealing member 30 is applied with an external force (in the direction of arrow b in FIG. 5) in the direction of expanding the medicine bag to the closed end 30-1, and the sealing member 30 is made of a fragile material such as foamed synthetic resin. Since it is formed, the sealing member 30 is broken at the closed end 30-1 as shown in FIG. That is, the sealing member 30 is divided into two parts 30A and 30B integrated on the opposite surface of the synthetic resin film constituting the drug bag 10, and the inside of the drug bag 10 is communicated with the discharge port 12 so that the mixed drug solution can be supplied. It can flow into the discharge port 12. Note that the destruction mode of the sealing member 30 due to external force is not necessarily divided into two parts by the respective welded portions as shown in FIG. 5, and those that are crushed into pieces are also included in the present invention. The opening may be formed so that the inside of the medicine bag 10 communicates with the discharge port 12 by destruction.

封止部材は合成樹脂に発泡材を混合し、加熱成形することにより構成することができる。そして、適当な発泡率に調整することで、確実な破壊が行われるように適切な強度設定が可能となる。合成樹脂素材としては薬剤バッグ10を構成する合成樹脂フィルムとの接着性の観点からは同質素材であることが好ましく、薬剤バッグ10がポリエチレンの場合は発泡素材もポリエチレン系の発泡素材であることが好ましい。   The sealing member can be constituted by mixing a foaming material with synthetic resin and thermoforming. Then, by adjusting to an appropriate foaming rate, it is possible to set an appropriate strength so that reliable destruction is performed. The synthetic resin material is preferably the same material from the viewpoint of adhesiveness with the synthetic resin film constituting the drug bag 10, and when the drug bag 10 is made of polyethylene, the foam material may be a polyethylene-based foam material. preferable.

また、封止部材30を構成する発泡素材を適当な通気性とすることにより、薬剤バッグ中の薬液蒸気の流通性を持たせることにより湿熱下で排気ポート12の滅菌を行うことができる点で有利である。即ち、複室容器の生産工程として滅菌工程を含み、通常は各隔室20, 22に薬液を収容した状態で加熱にて行うが、封止部材に通気性を持たせておくことで、薬剤バッグ10内の薬液蒸気が通気性封止部材30を介して排出ポート12に流通されるため、加圧滅菌時に排出ポート12内に薬剤蒸気が充填され、湿熱下での効率的な滅菌が可能となる。   In addition, by making the foam material constituting the sealing member 30 suitable air permeability, the exhaust port 12 can be sterilized under wet heat by providing the flowability of the chemical vapor in the drug bag. It is advantageous. That is, it includes a sterilization process as a production process of a multi-chamber container, and is usually performed by heating in a state where a chemical solution is stored in each of the compartments 20 and 22, but by providing the sealing member with air permeability, Since the chemical vapor in the bag 10 is circulated to the discharge port 12 through the breathable sealing member 30, the chemical vapor is filled in the discharge port 12 during autoclaving and efficient sterilization under humid heat is possible. It becomes.

封止部材30としては排出ポート12の素材と同一とし、かつ通常状態にあっては、薬剤バッグ10内部を排出ポート12に対して実質的に遮断する形状とするが、肉厚を排出ポート12のそれと比較して適度に薄くすることで脆弱化する構成もこの発明に包含される。この構成でも薬剤バッグ開通時の外力をポイントシールのような溶着部32を介して肉薄の封止部材に作用させ破壊・開通に至らしめることができる。   The sealing member 30 is the same as the material of the discharge port 12 and, in a normal state, has a shape that substantially blocks the inside of the drug bag 10 from the discharge port 12. The present invention also includes a configuration that is weakened by making it appropriately thin as compared with that of the present invention. Even in this configuration, the external force at the time of opening the medicine bag can be applied to the thin sealing member via the welded portion 32 such as a point seal, thereby leading to destruction / opening.

図1はこの発明の複室容器の平面図である。FIG. 1 is a plan view of a multi-chamber container according to the present invention. 図2は図1のII−II線に沿って現されるこの発明の複室容器の長手方向に沿った断面図である。FIG. 2 is a cross-sectional view along the longitudinal direction of the multi-chamber container according to the present invention, taken along line II-II in FIG. 図3は図2におけるIII−IIIに沿った矢視断面図である。3 is a cross-sectional view taken along the line III-III in FIG. 図4は図2におけるIV−IVに沿った矢視断面図である。4 is a cross-sectional view taken along line IV-IV in FIG. 図5は図2と同様であるが薬剤バッグ開通時における排出ポートとの接続部を部分的に示す。FIG. 5 is similar to FIG. 2 but partially shows a connection portion with the discharge port when the medicine bag is opened.

符号の説明Explanation of symbols

10…薬剤バッグ
12…排出ポート
14…強シール部
18…弱シール部(隔壁)
20, 22…第1、第2隔室
26…ゴム製内蓋
30…封止部材
32…ポイントシール部
DESCRIPTION OF SYMBOLS 10 ... Drug bag 12 ... Discharge port 14 ... Strong seal part 18 ... Weak seal part (partition wall)
20, 22 ... 1st, 2nd compartment 26 ... Rubber inner cover 30 ... Sealing member 32 ... Point seal part

Claims (3)

可撓性フィルムにて形成された薬剤バッグと、薬剤の排出のため薬剤バッグに装着された排出ポートと、薬剤バッグ内部をそれぞれの薬剤の収納のための複数の隔室に分離し、薬剤バッグに外部より印加される押圧力により剥離開通されるように薬剤バッグの対向内面を溶着して構成される隔壁と、前記排出ポートから薬剤バッグ内部に向けて延出し、脆弱素材にて形成され、排出ポートを薬剤バッグ内部に対して通常状態において実質的に閉鎖しかつ外力により破壊される封止部材と、薬剤バッグと封止部材との対向面を一体に接合する接合部とを具備し、前記封止部材は隔壁の剥離開通時の前記押圧力による薬剤バッグの拡開により前記接合部にて惹起される外力により破壊せしめられることにより、排出ポートを薬剤バッグ内部に連通せしめる開口部が形成される複室容器。   A medicine bag formed of a flexible film, a discharge port attached to the medicine bag for discharging medicine, and a plurality of compartments for storing each medicine are separated into the medicine bag. A partition configured to weld the opposite inner surface of the drug bag so as to be peeled open by a pressing force applied from the outside, and extends from the discharge port toward the inside of the drug bag, and is formed of a fragile material, A sealing member that substantially closes the discharge port with respect to the inside of the medicine bag in a normal state and is destroyed by an external force; and a joint portion that integrally joins the opposing surfaces of the medicine bag and the sealing member; The sealing member is broken by an external force generated at the joint portion by the expansion of the medicine bag by the pressing force when the partition wall is peeled and opened, so that the discharge port communicates with the inside of the medicine bag. Multi-chamber container opening occupied is formed. 請求項1に記載の発明において、封止部材の元となる脆弱素材は発泡合成樹脂である複室容器。   The multi-chamber container according to claim 1, wherein the brittle material that is a source of the sealing member is a foamed synthetic resin. 可撓性フィルムにて形成された薬剤バッグと、薬剤の排出のため薬剤バッグに装着された排出ポートと、排出ポートに設けられた栓体と、薬剤バッグ内部をそれぞれの薬剤の収納のための複数の隔室に分離し、それぞれの隔室に収納された薬剤の混合のため薬剤バッグに外部より印加される押圧力により剥離開通されるように薬剤バッグの対向内面を溶着する隔室とを備えた複室容器より薬剤排出を行う方法であって、前記排出ポートに、脆弱素材にて形成され、排出ポートから薬剤バッグの内部空洞に向けて延出し、排出ポートを薬剤バッグ内部に対して通常状態において実質的に閉鎖するように封止部材を具備させ、かつ薬剤バッグと封止部材との対向面を一体に接合し、通常時は薬剤バッグ内部を排出ポートに対して実質的に閉鎖するようにし、輸液の際に薬剤バッグを外部から加圧することにより惹起される液圧で隔壁を剥離させて前記複数の隔室を連通させること第1及び第2の隔室の薬剤を混合させると共に、隔壁の剥離により惹起される薬剤バッグの拡開により封止部材を破壊させて混合薬剤を排出ポートに導き、その後輸液具を栓体に穿刺することにより薬剤排出を開始するようにした複室容器からの薬剤排出方法。   A drug bag formed of a flexible film, a discharge port attached to the drug bag for discharging the drug, a plug provided in the discharge port, and the inside of the drug bag for storing each drug A compartment that is separated into a plurality of compartments and welds the opposing inner surfaces of the medicine bag so that the medicine bag is peeled open by a pressing force applied from the outside to mix the medicines stored in each compartment. A method for discharging a drug from a multi-chamber container provided, wherein the discharge port is formed of a fragile material, extends from the discharge port toward an internal cavity of the drug bag, and the discharge port is directed to the inside of the drug bag. The sealing member is provided so as to be substantially closed in a normal state, and the opposing surfaces of the medicine bag and the sealing member are joined together, and the inside of the medicine bag is normally substantially closed with respect to the discharge port. Do In addition, the partition walls are separated by fluid pressure caused by pressurizing the medicine bag from the outside during infusion, and the plurality of compartments are communicated with each other, and the medicines in the first and second compartments are mixed. A multi-chamber in which the sealing member is broken by the expansion of the drug bag caused by the separation of the partition wall, the mixed drug is guided to the discharge port, and then the drug discharge is started by puncturing the stopper with the infusion device How to drain the drug from the container.
JP2007164964A 2007-06-22 2007-06-22 Multi-chamber container Expired - Fee Related JP5223244B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007164964A JP5223244B2 (en) 2007-06-22 2007-06-22 Multi-chamber container

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007164964A JP5223244B2 (en) 2007-06-22 2007-06-22 Multi-chamber container

Publications (2)

Publication Number Publication Date
JP2009000343A true JP2009000343A (en) 2009-01-08
JP5223244B2 JP5223244B2 (en) 2013-06-26

Family

ID=40317391

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007164964A Expired - Fee Related JP5223244B2 (en) 2007-06-22 2007-06-22 Multi-chamber container

Country Status (1)

Country Link
JP (1) JP5223244B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011206301A (en) * 2010-03-30 2011-10-20 Terumo Corp Hollow body for medical container, discharge port for medical containers, medicine container for medical container and medical container

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000107257A (en) * 1998-10-06 2000-04-18 Terumo Corp Transfusion bag
JP2004248892A (en) * 2003-02-20 2004-09-09 Terumo Corp Medical container
JP2006020964A (en) * 2004-07-09 2006-01-26 Ajinomoto Co Inc Medical agent storage sealing body, and method for forming the same
JP2006280390A (en) * 2005-03-31 2006-10-19 Terumo Corp Medical container
JP2007050085A (en) * 2005-08-17 2007-03-01 Terumo Corp Medical container
JP3130683U (en) * 2007-01-23 2007-04-05 株式会社大塚製薬工場 Medical multi-chamber container
WO2007055355A1 (en) * 2005-11-14 2007-05-18 Ajinomoto Co., Inc. Multichamber container
JP2007185418A (en) * 2006-01-16 2007-07-26 Ajinomoto Co Inc Multi-chamber container

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000107257A (en) * 1998-10-06 2000-04-18 Terumo Corp Transfusion bag
JP2004248892A (en) * 2003-02-20 2004-09-09 Terumo Corp Medical container
JP2006020964A (en) * 2004-07-09 2006-01-26 Ajinomoto Co Inc Medical agent storage sealing body, and method for forming the same
JP2006280390A (en) * 2005-03-31 2006-10-19 Terumo Corp Medical container
JP2007050085A (en) * 2005-08-17 2007-03-01 Terumo Corp Medical container
WO2007055355A1 (en) * 2005-11-14 2007-05-18 Ajinomoto Co., Inc. Multichamber container
JP2007185418A (en) * 2006-01-16 2007-07-26 Ajinomoto Co Inc Multi-chamber container
JP3130683U (en) * 2007-01-23 2007-04-05 株式会社大塚製薬工場 Medical multi-chamber container

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011206301A (en) * 2010-03-30 2011-10-20 Terumo Corp Hollow body for medical container, discharge port for medical containers, medicine container for medical container and medical container

Also Published As

Publication number Publication date
JP5223244B2 (en) 2013-06-26

Similar Documents

Publication Publication Date Title
JP5299640B2 (en) Multi-chamber container
JP5418649B2 (en) Multi-chamber container
JP4463205B2 (en) Medical multi-chamber container and manufacturing method thereof
JP5057172B2 (en) Multi-chamber container
NO327788B1 (en) Flexible container for combined storage and administration of a drug solution and method for increasing the capacity of such a container
KR20090079220A (en) Multichamber container
WO2014103411A1 (en) Multi-chamber vessel
JP2007190161A (en) Double-chamber container
JP2005245677A (en) Medical multi-chamber container with unmixing-preventing mechanism
JP4535840B2 (en) Manufacturing method of medical multi-chamber container
JP5223244B2 (en) Multi-chamber container
JP4962733B2 (en) Multi-chamber container
JP4594178B2 (en) Multi-chamber container
WO2010082649A1 (en) Dual-chamber container
JP2006187558A (en) Medical container
JP4822860B2 (en) Medical multi-chamber container
JP2011131104A (en) Medical double-chamber container
JP4599918B2 (en) Drug storage sealing body and method for forming drug storage sealing body
JP2008061669A (en) Multi-chamber container
JP2009018038A (en) Multi-chambered container
JP2007185418A (en) Multi-chamber container
JP2006141857A (en) Medical multi chamber container stored in packaging material
JP2000262589A (en) Double chamber container
JP4568521B2 (en) Method for producing medical container and medical container
JP5363788B2 (en) Multi-chamber container

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100319

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120113

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20120119

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120710

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120903

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130212

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130225

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160322

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees